[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-369880-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-369880-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","jchain-a-prognostic-marker-based-on-pan-cancer-analysis-to-inhibit-breast-cancer-progression","JCHAIN - A Prognostic Marker Based on Pan-Cancer Analysis to Inhibit Breast Cancer Progression","","Pan-cancer analysis evaluates JCHAIN, an immunoglobulin-linked chain implicated in oncogenesis and immune regulation. The study determines JCHAIN expression patterns and prognostic value using gene and protein datasets across multiple cancers, supported by univariate Cox regression and Kaplan–Meier analysis. Immune infiltration associations are assessed through TISIDB and TIMER, complemented by single-cell and spatial transcriptomic analyses. Breast cancer results show negative correlation with cellular stemness and enrichment in immune response, B cell activation, and JAK-STAT signalling, with IL-2/STAT4-linked functional inhibition of migration and invasion.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/jchain-a-prognostic-marker-based-on-pan-cancer-analysis-to-inhibit-breast-cancer-progression/369880/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/jchain-a-prognostic-marker-based-on-pan-cancer-analysis-to-inhibit-breast-cancer-progression/369880.png","ImageObject",300,407,{"name":42,"@type":43},"Aldword","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the primary goal of the pan-cancer analysis in this study?","Question",{"text":63,"@type":64},"To assess the expression profile and prognostic significance of JCHAIN across diverse cancers, and to explore its immune-related functions and mechanisms.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How did the study evaluate the prognostic significance of JCHAIN?",{"text":68,"@type":64},"It analyzed JCHAIN using univariate Cox regression and Kaplan–Meier tools across multiple cancer types.",{"name":70,"@type":61,"acceptedAnswer":71},"What key findings were reported for breast cancer?",{"text":72,"@type":64},"JCHAIN expression was negatively correlated with cellular stemness, involved in immune-related pathways including JAK-STAT signalling, and overexpression inhibited breast cancer cell migration and invasion via IL-2/STAT4.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},369880,1790248203,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":112,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},2336478940917,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Article  \nJCHAIN: A Prognostic Marker Based on Pan-Cancer Analysis to Inhibit Breast Cancer Progression  \nJinfeng Zhao *, Wanquan Chen, Longpeng Li, Zhibin Zhang and Yaxin Wang  \nAcademic Editor: Yutaka Suzuki  \nReceived: 14 August 2025  \nRevised: 2 September 2025  \nAccepted: 8 September 2025  \nPublished: 11 September 2025  \nCitation: Zhao, J.; Chen, W.; Li, L.; Zhang, Z.; Wang, Y. JCHAIN: A Prognostic Marker Based on  \nPan-Cancer Analysis to Inhibit Breast Cancer Progression. Genes 2025, 16, 1070. [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)genes16091070  \nCopyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \nInstitute of Physical Education and Sport, Shanxi University, Taiyuan 030006, China  \n* [Correspondence: zjf@sxu.edu.cn](Correspondence: zjf@sxu.edu.cn)  \nAbstract  \nBackground/Objectives: The JCHAIN (immunoglobulin-linked chain) is a multimeric IgA and IgM-linked chain whose involvement in oncogenesis and immunomodulation is unknown. The goal of this work was to conduct a comprehensive pan-cancer analysis of the JCHAIN to determine its expression profile, prognostic significance, immune infiltration, and function in diverse malignancies. Methods: We performed pan-cancer analysis of gene expression data and protein expression data of JCHAIN using multiple databases, and analysed the prognostic significance of JCHAIN in a variety of cancers using univariate Cox analysis and Kaplan–Meier tools. The relationship between JCHAIN and immune cell infiltration was analysed via the TISIDB and TIMER websites, while single-cell and spatial transcriptomic analyses were performed to analyse the relationship between JCHAIN and the immune microenvironment. Mutations in the JCHAIN and their connection with methylation were then investigated using the cBioPortal and UALCAN websites. Afterwards, the function of JCHAIN was analysed by KEGG as well as GSEA, and the function of JCHAIN in breast cancer cells was verified by in vitro experiments. Results: The expression of the JCHAIN gene shows significant differences in most cancers, and its high expression is associated with a favourable prognosis. In most cancers, JCHAIN gene expression is closely linked to immune-related genes, immune cells, and methylation, as well as to being affected by mutations. In breast cancer, we found that the JCHAIN was negatively correlated with cellular stemness. Enrichment analysis indicated that the JCHAIN was involved in immune responses, B cell activation, and JAK-STAT signalling pathways. Functional experiments showed that overexpression of the JCHAIN inhibited tumour migration and invasion, which may be closely related to the activation of the IL-2/STAT4 signalling pathway. Conclusions: We found that JCHAIN can be used as a diagnostic and prognostic marker for a variety of cancers by pan-cancer analysis and verified that JCHAIN affects breast cancer cell progression through IL-2/STAT4 by in vitro experiments.  \nKeywords: JCHAIN; immune microenvironment; prognostic marker; IL2-STAT4 signalling pathway; breast cancer  \n1. Introduction  \nAccording to the latest estimates of the International Agency for Research on Cancer (IARC), there were nearly 20 million new cancer cases and 9.7 million cancer deaths in 2022 [1] . Currently, significant progress has been made in the treatment of cancer with surgery, targeted therapy, and chemotherapy [2], However, cytotoxicity and drug resistance can occur during treatment [3], and the degree of recurrence and metastasis after treatment varies greatly by cancer stage, which seriously affects the prognosis of  \npatients [4] . Therefore, the identification of novel diagnostic and prognostic biomarkers is imp","cbCaikYeda5hFeCz","https://ap.wps.com/l/cbCaikYeda5hFeCz","pdf",18874339,"English","# Abstract\n# 1. Introduction","[{\"question\":\"What was the primary goal of the pan-cancer analysis in this study?\",\"answer\":\"To assess the expression profile and prognostic significance of JCHAIN across diverse cancers, and to explore its immune-related functions and mechanisms.\"},{\"question\":\"How did the study evaluate the prognostic significance of JCHAIN?\",\"answer\":\"It analyzed JCHAIN using univariate Cox regression and Kaplan–Meier tools across multiple cancer types.\"},{\"question\":\"What key findings were reported for breast cancer?\",\"answer\":\"JCHAIN expression was negatively correlated with cellular stemness, involved in immune-related pathways including JAK-STAT signalling, and overexpression inhibited breast cancer cell migration and invasion via IL-2/STAT4.\"}]","JCHAIN - A Prognostic Marker Based on Pan-Cancer Analysis to Inhibit Breast Cancer Progression | PDF",1790185050,76,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/38c7b694ea2f6d82468f0838c68fb786.webp",983,1390,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/25dedea104d410002e00091d57e98957.webp",982,1388,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f45ff9a0f0698b75d405ebdbad8a3ac1.webp",981,1387,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2c42c4f3a5077912780c1ff6bce4a041.webp",980,1385]